Obesity Drug Linked to Suicidal Thoughts

The manufacturer of the antiobesity drug rimonobant, sold under the Acomplia brand, has informed the FDA that users of the medication suffer from a higher risk of suicidal thoughts. Sanofi-Aventis also told the FDA that it doesn't recommend the drug for people who suffer from depression.